Switch to:

CRISPR Therapeutics AG Gross-Profit-to-Asset %

: 0.02% (As of Jun. 2020)
View and export this data going back to 2016. Start your Free Trial

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. CRISPR Therapeutics AG's annualized Gross Profit for the quarter that ended in Jun. 2020 was $0.2 Mil. CRISPR Therapeutics AG's average Total Assets over the quarter that ended in Jun. 2020 was $1,026.9 Mil. Therefore, CRISPR Therapeutics AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2020 was 0.02%.


CRISPR Therapeutics AG Gross-Profit-to-Asset % Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Gross-Profit-to-Asset % Premium Member Only 0.31 2.05 13.30 0.82 37.23

CRISPR Therapeutics AG Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Gross-Profit-to-Asset % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 139.56 34.47 0.06 0.02

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


CRISPR Therapeutics AG Gross-Profit-to-Asset % Distribution

* The bar in red indicates where CRISPR Therapeutics AG's Gross-Profit-to-Asset % falls into.



CRISPR Therapeutics AG Gross-Profit-to-Asset % Calculation

CRISPR Therapeutics AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2019 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2019 )/( (Total Assets (A: Dec. 2018 )+Total Assets (A: Dec. 2019 ))/ count )
=289.59/( (489.016+1066.752)/ 2 )
=289.59/777.884
=37.23 %

CRISPR Therapeutics AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2020 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2020 )/( (Total Assets (Q: Mar. 2020 )+Total Assets (Q: Jun. 2020 ))/ count )
=0.176/( (1007.3+1046.532)/ 2 )
=0.176/1026.916
=0.02 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2020) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


CRISPR Therapeutics AG Gross-Profit-to-Asset % Related Terms


CRISPR Therapeutics AG Gross-Profit-to-Asset % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)